Keywords: Brazil, Atrial fibrillation, Market forecass, Boehringer, Pradaxa, Bayer, Xarelto, Bristol-Myers, Eliquis, Daiichi Sankyo, Lixiana, Decision Resources

Brazil's atrial fibrillation market expected to grow at 31% pa over next five years

Article | 22 January 2013

• Print This

The Brazilian market for atrial fibrillation will increase at a rate of 31% per year from 2011 to 2016, according to advisory firm& ...

Enjoying this article? To continue reading you need to login or subscribe.